There is a glimmer of good news in the war against COVID-19, as the vaccine being developed by the University of Oxford and AstraZeneca is showing immune responses in the elderly. Multiple COVID-19 vaccines are being developed, and Eric Sorensen explains why the Oxford one appears to be the frontrunner.
- Alberta professor running COVID-19 study says ‘normal’ is far off, multiple steps ahead of vaccination
- Coronavirus vaccine by Oxford-AstraZeneca produces immune response among adults